Category: misconduct investigations

Two papers to be retracted after ORI finds misconduct by Boston University cancer researcher

courtesy Nature Publishing Group

The U.S. Department of Health and Human Services’ Office of Research Integrity (ORI) has found that a Boston University cancer researcher made up experiments reported in two papers funded by National Cancer Institute and National Institutes of Health grants. According to the ORI notice:

Sheng Wang, PhD, Boston University School of Medicine Cancer Research Center: Based on the Respondent’s acceptance of ORI’s research misconduct findings, ORI found that Dr. Sheng Wang, who has been an Assistant Professor, Department of Medicine, Boston University School of Medicine Cancer Research Center (BUSM), engaged in research misconduct in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH), grants R01 CA102940 and R01 CA101992.

The two papers were: Continue reading Two papers to be retracted after ORI finds misconduct by Boston University cancer researcher

University investigating leading German derm lab that retracted Immunology paper

The laboratory of Michael Hertl, a German dermatology researcher with an international reputation, is under investigation for possible misconduct, according to a legal official at Hertl’s institution, Philipps-Universitat Marburg.

The acknowledgement was prompted by our query earlier this week about a 2008 paper from Hertl’s group that had been retracted by the journal Immunology. According to the July 25 retraction notice: Continue reading University investigating leading German derm lab that retracted Immunology paper

Carsten Carlberg out at University of Luxembourg

The University of Luxembourg has fired researcher Carsten Carlberg after concluding that his name was a drag on the institution.

Here’s an English  translation of an article about the firing, which many readers were kind enough to forward to us: Continue reading Carsten Carlberg out at University of Luxembourg

Four mysterious retractions in the JBC for a group whose PI recently passed away

The Journal of Biological Chemistry (JBC) has retracted four studies done in a Mount Sinai School of Medicine lab whose principal investigator died last month. The studies, by the late Maria Diverse-Pierluissi and colleagues, were as follows:

According to a Mount Sinai release, Diverse-Pierluissi died on May 7 of this year. The retractions are dated June 17, and all say the same thing: Continue reading Four mysterious retractions in the JBC for a group whose PI recently passed away

Update on Journal of Neuroscience retractions: Authors being investigated. Plus, editor explains why notices say nothing

We have updates on the two mysterious Journal of Neuroscience retractions we reported on yesterday. One is that we have learned that there is a university investigation into the work of one of the teams that retracted one of the studies. More on that in a bit.

Two, the journal’s editor, John Maunsell, responded to our request for comment, and we’re quoting his entire email (with annotation) because we think it raises important issues: Continue reading Update on Journal of Neuroscience retractions: Authors being investigated. Plus, editor explains why notices say nothing

Journal of Neuroscience retracts two, one 13 years old

The June 8 issue of the Journal of Neuroscience includes two retractions:

The notices are completely uninformative. They read: Continue reading Journal of Neuroscience retracts two, one 13 years old

U. Luxembourg official offers more detail — or tries to — on Carsten Carlberg case

We’re continuing to try to find out more about the developing story surrounding Carsten Carlberg. Carlberg, as we have reported, was senior author on two papers retracted last year because one of the authors, a graduate student in Carlberg’s lab at the University of Eastern Finland  (formerly Kuopio), fabricated data.

Carlberg holds a dual appointment with the University of Luxembourg, which recently announced the results of a months-long investigation into his behavior.

We have been relying on unofficial translations of a May 20th statement by university officials such as this one, by a generous Retraction Watch reader: Continue reading U. Luxembourg official offers more detail — or tries to — on Carsten Carlberg case

*Grad student’s misdeeds may cost prof Carsten Carlberg a job

In November, we reported on two retractions in Cell and the Journal of Molecular Biology involving misconduct in the lab of biochemist Carsten Carlberg, of the University of Eastern Finland, in Kuopio.

Carlberg also holds an appointment in computational biology at the University of Luxembourg, which last year launched an investigation — at his behest, he says — into the case. Well, the officials in Luxembourg finally have spoken, and Carlberg, it seems, may soon be out of his job there, the Tageblatt newspaper reports.

Carlberg, to our knowledge, has never been accused of ethical violations in the case, and the inquiry didn’t change that. Rather, the bad actor appears to be his former post-doc graduate student in Finland, Tatjana Degenhardt. But the University of Luxembourg may seek to dismiss Carlberg after concluding that, as the senior author of the two retracted articles, he bore responsibility for the validity of the results and, by implication, the deception.

Ironically, Carlberg says he asked the school to undertake the investigation even though none of Degenhardt’s research had been conducted using that school’s resources. In an email today to Retraction Watch, he writes: Continue reading *Grad student’s misdeeds may cost prof Carsten Carlberg a job

Blood retracts two, including a disputed paper from the Karolinska Institute

The journal Blood has two retractions this month, one of which seems particularly interesting. So let’s deal with the other one first.

The paper, “MicroRNAs 15a/16-1 function as tumor suppressor genes in multiple myeloma,” appeared online in October 2010. But according to the retraction notice, the authors

have recently discovered that the cell lines used in their paper were inadvertently misidentified. The cell lines utilized in the paper have now been found to contain the bcr/abl translocation and most likely represent the K562 CML cell line, instead of MMS1 and RPM1 myeloma cell lines. Due to this issue, the relevance of the findings to myeloma and thus, the conclusions of the paper, are not supported by the data. The authors apologize to the readers, reviewers, and editors of Blood for publishing these erroneous data.

That seems straightforward enough, and we couldn’t find any evidence that this problem affected other publications.

The second paper, however, could be more significant. Continue reading Blood retracts two, including a disputed paper from the Karolinska Institute

Data fraud at Emory leads to retractions of three cardiology papers

An investigation by Emory University in Atlanta has led to the retractions of three articles containing falsified data, but the ambiguous wording of the notices leaves us wondering if they are implying more than they state.

Two of the papers appeared in the journal Arteriosclerosis, Thrombosis, and Vascular Biology. The notices in ATVB implicate a researcher named Lian Zuo, who worked in Emory’s division of cardiology.

Here’s one: Continue reading Data fraud at Emory leads to retractions of three cardiology papers